Among 77,310 first-time users of semaglutide for weight loss, over half (with a median age of 50 and 72 percent women) were no longer taking it after one yearwith 18 percent, 31 percent and 42 percent stopping treatment within three, six and nine months, respectively
Clinical studies indicate that individuals may lose between 5% and 15% of their initial body weight over a few months when combining Semaglutide GLP-1 with a reduced-calorie diet and increased physical activity
Avoid exposing your pen to direct sunlight, heat sources, or rapid temperature swings, all of which increase bubble formation and reduce medication stability
Originally developed for diabetes management, this FDA-approved medication works by mimicking a natural hormone called GLP-1, which regulates appetite and digestion
Average weight loss at week 52 was 15.6 percent, and at week 104 (two years), it was 15.2 percent
GIP/GLP-1 Dual Agonists The research shows that tirzepatide outperforms semaglutide at both weight loss and blood sugar control
